Literature DB >> 25296731

Genetic determinants of uveal melanoma.

Jasbir Kaur1, Manzoor Ahmad Malik, Rishabh Gulati, Shorya Vardhan Azad, Sandeep Goswami.   

Abstract

Melanoma of the uveal tract is the most common primary intraocular tumor in adults. With advances in genetic research and the open source access of genetic databases, new insights are emerging into the molecular changes of this cancer. As with most other tumors, the driving force behind such research is the hope of finding and developing new modalities for therapeutic purposes, prognosticating disease and understanding risk factors for metastasis. With advances in proteomics, cytogenetics and gene profiling, the stage is set to unearth the underlying genetic basis which can in the future be a target of therapeutic modalities. This article describes the cytogenetic, molecular pathogenesis, and prognostic factors along with the most important findings and their attribution to current and future management of uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296731     DOI: 10.1007/s13277-014-2681-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  47 in total

1.  Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.

Authors:  Thomas van den Bosch; Jackelien G M van Beek; Jolanda Vaarwater; Robert M Verdijk; Nicole C Naus; Dion Paridaens; Annelies de Klein; Emine Kiliç
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

2.  Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.

Authors:  Thomas Häusler; Andreas Stang; Gerasimos Anastassiou; Karl-Heinz Jöckel; Stefanie Mrzyk; Bernhard Horsthemke; Dietmar R Lohmann; Michael Zeschnigk
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

3.  Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.

Authors:  S L Merbs; D Sidransky
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-03       Impact factor: 4.799

4.  NBS1 expression as a prognostic marker in uveal melanoma.

Authors:  Justis P Ehlers; J William Harbour
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

5.  Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.

Authors:  Hua Yang; Martine J Jager; Hans E Grossniklaus
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

Review 6.  Molecular pathways mediating liver metastasis in patients with uveal melanoma.

Authors:  Silvin Bakalian; Jean-Claude Marshall; Patrick Logan; Dana Faingold; Shawn Maloney; Sebastian Di Cesare; Claudia Martins; Bruno F Fernandes; Miguel N Burnier
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

Review 7.  Emerging insights into the molecular pathogenesis of uveal melanoma.

Authors:  Solange Landreville; Olga A Agapova; J William Harbour
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

8.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  Metastasis from untreated uveal melanomas.

Authors:  J M Pach; D M Robertson
Journal:  Arch Ophthalmol       Date:  1986-11

10.  In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines.

Authors:  Sebastian Di Cesare; Jean-Claude Marshall; Bruno F Fernandes; Patrick Logan; Emilia Antecka; Vasco Bravo Filho; Miguel N Burnier
Journal:  Cancer Cell Int       Date:  2007-11-14       Impact factor: 5.722

View more
  3 in total

1.  P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.

Authors:  Hui Pan; Hongyan Ni; LeiLei Zhang; Yue Xing; Jiayan Fan; Peng Li; Tianyuan Li; Renbing Jia; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Tumour Biol       Date:  2016-07-28

2.  DNA Repair Genes Are Associated with Subtype Classification, Prognosis, and Immune Infiltration in Uveal Melanoma.

Authors:  Tao Wang; Dingwei Liu; Lin Wang; Mengfan Liu; Wenwen Duan; Jinlin Yi; Yunmin Yi
Journal:  J Oncol       Date:  2022-01-19       Impact factor: 4.375

3.  A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma.

Authors:  Lingxiao Xie; Weizhou Yue; Khaled Ibrahim; Jie Shen
Journal:  Pharmaceutics       Date:  2021-08-25       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.